BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 238376)

  • 1. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG; Javory AF; Beaujouan JC; Rossier BJ; Glowinski J
    Brain Res; 1975 Feb; 84(2):227-44. PubMed ID: 234276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH; Van Woert MH
    Nature; 1974 Oct; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of acetylcholine in the neostriatum by dopamine and 5-hydroxytryptamine.
    Butcher SH; Cho AK
    Proc West Pharmacol Soc; 1976; 19():130-5. PubMed ID: 995978
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical evidence for denervation supersensitivity: the effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels.
    Fibiger HC; Grewaal DS
    Life Sci; 1974 Jul; 15(1):57-63. PubMed ID: 4549908
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S; Ladinsky H; Bianchi S
    Eur J Pharmacol; 1975; 33(2):345-51. PubMed ID: 1183479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of brain cholinergic mechanisms in the action of chlorpromazine.
    Trabucchi M; Cheney D; Racagni G; Costa E
    Nature; 1974 Jun; 249(458):664-6. PubMed ID: 4833805
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 13. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
    Grace AA; Bunney BS
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1092-100. PubMed ID: 3746660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons.
    Iwatsubo K; Clouet DH
    J Pharmacol Exp Ther; 1977 Aug; 202(2):429-36. PubMed ID: 886472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.